Gapping down
In reaction to disappointing earnings/guidance:
- QGEN -18.9% (reaffirms Q3 EPS, sees revenue below guidance; also announces CEO transition; CEO Peer M. Schatz to depart to pursue new opportunities), DZSI -17.9%, DPZ -4.8%
Select EU financial related names showing weakness:
- DB -2.5%, ING -2.2%, SAN -2.1%, BCS -1.4%, LYG -1.2%, HSBC -0.8%
Other news:
- AMBA -12.4% (on report that the Department of Commerce will blacklist its customer Hikvision)
- CVM -4.4% (attributed to cautious Stat News report from Adam Feuerstein)
- AQN -3.3% (commences underwritten marketed public offering of 21,520,804 common shares)
- SDC -2.1% (rebounding from yesterday's 8% pullback; co commented after the bell on analyst initiations)
- BA -1.5% (WSJ article stating dispute between US and European regulators could further delay Boeing (BA) 737 Max 8's return to flight)
- JAZZ -1.3% (CFO Matthew Young to resign effective as of October 25 to pursue a leadership opportunity with a privately-held healthcare company)
Analyst comments:
- PBYI -7.5% (downgraded to Sell from Neutral at Goldman)
- NKTR -7.1% (downgraded to Sell from Buy at Goldman)
- FTSI -3% (downgraded to Underperform from Neutral at BofA/Merrill)
- PTEN -2.6% (downgraded to Neutral from Buy at BofA/Merrill)
- HP -2% (downgraded to Neutral from Buy at BofA/Merrill)
- TERP -2% (downgraded to Equal Weight from Overweight at Barclays)
- ORCL -1.3% (downgraded to Hold from Buy at Jefferies)
- JBHT -1.2% (downgraded to Neutral from Positive at Susquehanna)
- BEN -1% (initiated with Underperform at BMO Capital Markets)
- LOW -0.7% (coverage downgraded/assumed to Mkt Perform from Outperform at Raymond James)